184 related articles for article (PubMed ID: 30903237)
21. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
22. [Pharmaco-epidemiology of antipsychotic prescription practices for schizophrenic patients (1995 and 1998 cross sectional surveys)].
Lachaux B; Casadebaig F; Philippe A; Ardiet G
Encephale; 2004; 30(1):46-51. PubMed ID: 15029076
[TBL] [Abstract][Full Text] [Related]
23. Psychiatric care utilization among older people with intellectual disability in comparison with the general population: a register study.
Axmon A; Björne P; Nylander L; Ahlström G
BMC Psychiatry; 2016 Nov; 16(1):389. PubMed ID: 27829383
[TBL] [Abstract][Full Text] [Related]
24. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
25. Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study.
Zaal RJ; van der Kaaij AD; Evenhuis HM; van den Bemt PM
Res Dev Disabil; 2013 May; 34(5):1656-62. PubMed ID: 23501585
[TBL] [Abstract][Full Text] [Related]
26. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
[TBL] [Abstract][Full Text] [Related]
27. Study on the use of Antipsychotic Medication in an Intellectual Disability (ID) community caseload.
Thalitaya MD; Reynolds C; Ismail I
Psychiatr Danub; 2017 Sep; 29(Suppl 3):578-583. PubMed ID: 28953833
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?
Tsiouris JA
J Intellect Disabil Res; 2010 Jan; 54(1):1-16. PubMed ID: 20122096
[TBL] [Abstract][Full Text] [Related]
29. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of antipsychotic prescriptions among patients with anxiety disorders treated in inpatient and outpatient psychiatric settings.
Weber SR; Wehr AM; Duchemin AM
J Affect Disord; 2016 Feb; 191():292-9. PubMed ID: 26688499
[TBL] [Abstract][Full Text] [Related]
31. Healthcare utilisation patterns among older people with intellectual disability and with affective and anxiety diagnoses in comparison with the general population.
El Mrayyan N; Bökberg C; Eberhard J; Ahlström G
Aging Ment Health; 2021 Aug; 25(8):1525-1534. PubMed ID: 32208744
[TBL] [Abstract][Full Text] [Related]
32. Hospital readmissions among older people with intellectual disability in comparison with the general population.
Axmon A; Björkman M; Ahlström G
J Intellect Disabil Res; 2019 Jun; 63(6):593-602. PubMed ID: 30734976
[TBL] [Abstract][Full Text] [Related]
33. Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription.
de Kuijper G; Hoekstra P; Visser F; Scholte FA; Penning C; Evenhuis H
J Intellect Disabil Res; 2010 Jul; 54(7):659-67. PubMed ID: 20426795
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis.
Park SY; Cervesi C; Galling B; Molteni S; Walyzada F; Ameis SH; Gerhard T; Olfson M; Correll CU
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):456-468.e4. PubMed ID: 27238064
[TBL] [Abstract][Full Text] [Related]
35. Zuclopenthixol dihydrochloride for schizophrenia.
Kumar A; Strech D
Cochrane Database Syst Rev; 2005 Oct; (4):CD005474. PubMed ID: 16235403
[TBL] [Abstract][Full Text] [Related]
36. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
37. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
Shankar R; Wilcock M
PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
[TBL] [Abstract][Full Text] [Related]
38. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
39. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
[TBL] [Abstract][Full Text] [Related]
40. Patients with and without intellectual disability seeking outpatient psychiatric services: diagnoses and prescribing pattern.
Hurley AD; Folstein M; Lam N
J Intellect Disabil Res; 2003 Jan; 47(Pt 1):39-50. PubMed ID: 12558694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
